KM Financial Solutions | Pfizer to invest up to $500 mln in public drug developers
74210
post-template-default,single,single-post,postid-74210,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Pfizer to invest up to $500 mln in public drug developers

Pfizer to invest up to $500 mln in public drug developers

Pfizer Inc said on Tuesday it
will invest up to $500 million into publicly traded drug
developers to fund their treatment candidates and provide access
to the U.S. drugmaker’s scientific expertise.

No Comments

Sorry, the comment form is closed at this time.